Early Phase Cancer Immunotherapy
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2018.
|
Έκδοση: | 1st ed. 2018. |
Σειρά: | Current Cancer Research,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins
- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy
- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies
- Chapter 4 Radiographic Evaluation of Immunotherapy
- Chapter 5 Cellular Therapy
- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation
- Chapter 7 Early Phase Cancer Immunotherapy
- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators
- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials
- Chapter 10 Thoracic Immunotherapy.